These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38671007)

  • 1. A new prediction nomogram of non-sentinel lymph node metastasis in cT1-2 breast cancer patients with positive sentinel lymph nodes.
    Yang L; Zhao X; Yang L; Chang Y; Cao C; Li X; Wang Q; Song Z
    Sci Rep; 2024 Apr; 14(1):9596. PubMed ID: 38671007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.
    Ryu JM; Lee SK; Kim JY; Yu J; Kim SW; Lee JE; Han SH; Jung YS; Nam SJ
    Clin Breast Cancer; 2017 Nov; 17(7):550-558. PubMed ID: 28454926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Non-sentinel Lymph Node Metastasis in a Chinese Breast Cancer Population with 1-2 Positive Sentinel Nodes: Development and Assessment of a New Predictive Nomogram.
    Chen JY; Chen JJ; Xue JY; Chen Y; Liu GY; Han QX; Yang WT; Shen ZZ; Shao ZM; Wu J
    World J Surg; 2015 Dec; 39(12):2919-27. PubMed ID: 26324157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A nomogram to predict non-sentinel lymph node metastasis for breast cancer patients with positive axillary sentinel lymph node].
    Yang ZB; Huang Z; Wang SL; Tang Y; Jing H; Wang JY; Zhang JH; Yang Y; Song YW; Fang H; Jin J; Liu YP; Qi SN; Li N; Tang Y; Lu NN; Chen B; Wang X; Gao JD; Wang J; Xuan LX; Fang Y; Li YX
    Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):653-659. PubMed ID: 32867457
    [No Abstract]   [Full Text] [Related]  

  • 5. Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer?
    Madekivi V; Boström P; Karlsson A; Aaltonen R; Salminen E
    Acta Oncol; 2020 Jun; 59(6):689-695. PubMed ID: 32148141
    [No Abstract]   [Full Text] [Related]  

  • 6. Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases.
    Zheng J; Cai S; Song H; Wang Y; Han X; Wu H; Gao Z; Qiu F
    Medicine (Baltimore); 2018 Nov; 97(44):e13015. PubMed ID: 30383658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.
    Sa-Nguanraksa D; O-Charoenrat E; Kulprom A; Samarnthai N; Lohsiriwat V; Nimpoonsri K; O-Charoenrat P
    Breast Cancer; 2019 Jul; 26(4):471-477. PubMed ID: 30617675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of non-sentinel lymph node metastasis in breast cancer with 1-2 sentinel lymph node macrometastases underwent total mastectomy: a case-control study.
    Huang Z; Wu Z; Zou QQ; Xie YJ; Li LH; Huang YP; Wu FM; Huang D; Pan YH; Yang JR
    World J Surg Oncol; 2023 Apr; 21(1):125. PubMed ID: 37024930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients.
    Kohrt HE; Olshen RA; Bermas HR; Goodson WH; Wood DJ; Henry S; Rouse RV; Bailey L; Philben VJ; Dirbas FM; Dunn JJ; Johnson DL; Wapnir IL; Carlson RW; Stockdale FE; Hansen NM; Jeffrey SS;
    BMC Cancer; 2008 Mar; 8():66. PubMed ID: 18315887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study.
    Murata T; Watase C; Shiino S; Kurita A; Ogawa A; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
    World J Surg Oncol; 2022 Sep; 20(1):314. PubMed ID: 36171615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes.
    Yang Z; Lan X; Huang Z; Yang Y; Tang Y; Jing H; Wang J; Zhang J; Wang X; Gao J; Wang J; Xuan L; Fang Y; Ying J; Li Y; Huang X; Wang S
    Breast; 2020 Oct; 53():143-151. PubMed ID: 32823167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.
    Shimazu K; Sato N; Ogiya A; Sota Y; Yotsumoto D; Ishikawa T; Nakamura S; Kinoshita T; Tsuda H; Ohi Y; Akiyama F; Noguchi S
    Ann Surg Oncol; 2018 Sep; 25(9):2603-2611. PubMed ID: 29978372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram to predict non-sentinel lymph node metastasis in patients with initial cN+ breast cancer that downstages to cN0 after neoadjuvant chemotherapy.
    Cheng M; Zhuang X; Zhang L; Zhu T; Lin Y; Yang M; Ji F; Yang C; Gao H; Wang K
    J Surg Oncol; 2020 Sep; 122(3):373-381. PubMed ID: 32436217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-dimensional nomogram to predict non-sentinel lymph node metastases in T1-2HR+ breast cancer.
    Xiang K; Chen J; Min Y; Chen H; Yang J; Hu D; Han Y; Yin G; Feng Y
    Front Endocrinol (Lausanne); 2023; 14():1121394. PubMed ID: 37476497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of T Stages on the Choice of Axillary Evaluation Modality in Breast Cancer Patients With 1-2 Sentinel Lymph Node Metastases.
    Liu D; Chang L; Zhao X; Dai L; Cui H; Liu P; Zhai Z; Wu H; Ma X; Kang H
    Clin Breast Cancer; 2024 Jun; 24(4):e232-e243.e1. PubMed ID: 38368246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
    Mittendorf EA; Hunt KK; Boughey JC; Bassett R; Degnim AC; Harrell R; Yi M; Meric-Bernstam F; Ross MI; Babiera GV; Kuerer HM; Hwang RF
    Ann Surg; 2012 Jan; 255(1):109-15. PubMed ID: 22167004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nomogram for decision-making assistance on exemption of axillary lymph node dissection in T1-2 breast cancer with only one sentinel lymph node metastasis.
    Liu L; Lin Y; Li G; Zhang L; Zhang X; Wu J; Wang X; Yang Y; Xu S
    Front Oncol; 2022; 12():924298. PubMed ID: 36172144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Predictive Nomogram including Serum Lipoprotein a Level for Nonsentinel Lymph Node Metastases in Chinese Breast Cancer Patients with Positive Sentinel Lymph Node Metastases.
    Fang Z; Wang R; Yang C; Wang D; Chen W; Lin B; Gong D; Li S; Liang J; Liang X; Zeng C; Li J; Wang K; Lv W
    Dis Markers; 2021; 2021():7879508. PubMed ID: 34853623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a prediction model based on LASSO regression to evaluate the risk of non-sentinel lymph node metastasis in Chinese breast cancer patients with 1-2 positive sentinel lymph nodes.
    Meng L; Zheng T; Wang Y; Li Z; Xiao Q; He J; Tan J
    Sci Rep; 2021 Oct; 11(1):19972. PubMed ID: 34620978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
    Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
    Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.